Category - Pharma Industry News
Regeneron halts enrolment of severely ill patients in COVID-19 antibody trial
EMA begins evaluation of filgotinib for ulcerative colitis
Oxford BioDynamics enters strategic partnership with Boca Biolistics
Lilly, Incyte tout new baricitinib data in eczema
Novo Nordisk’s Saxenda bags NICE recommendation
EMA reviewing Biogen’s potential Alzheimer’s drug for use in the EU
Roche’s Tecentriq/Avastin combination approved by European Commission
New study assessing antibiotics for COVID-19 sepsis